Vincrex

ANDA 70867, held by Bristol Myers Squibb. Vincristine Sulfate.

As of Nov 15, 2026, ANDA 70867 (Vincrex), held by Bristol Myers Squibb, was first approved by FDA on Jul 12, 1988, with 2 approved supplements and 0 published complete response letters.

First approved: Jul 12, 1988
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Jul 12, 1988	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Vincrex5MG/VIAL · injectable;injection	Vincristine Sulfate	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Apr 17, 1991	Supplement 2Labeling	Approved	None posted
Aug 7, 1990	Supplement 1Labeling	Approved	None posted
Jul 12, 1988	Original application	Approved	None posted

Identifiers

Application: ANDA 70867
Drugs@FDA: Overview at FDA
Company: Bristol-Myers Squibb

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters